Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,390.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 4,100.00
  • 52 Week Low: 2,950.00
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 1,046
  • Market Cap: £174.34m
  • Beta: 0.18

Latest Deals

Traded Action Notifier PriceAmountValue
25-Oct-19 Sell Ian James Nicholson 3,158.67p 2,500 £78,966.75

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
25-Oct-19 Sell Ian James Nicholson 3,158.67p 2,500 £78,966.75

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 428,176 £14,515,166
Ian James Nicholson 15,500 £525,450

Major Shareholders

Notifier** Holding Value*
Castlefield Fund Partners Limited 985,000 £33,391,500
Liontrust Investment Partners LLP 522,411 £17,709,733
Canaccord Genuity Group Inc 514,643 £17,446,398
Miton Group plc 508,135 £17,225,776
Gresham House Asset Management Limited 355,675 £12,057,382
The Diverse Income Trust plc 302,300 £10,247,970
Wasatch Advisors, Inc. 265,000 £8,983,500
Adrian Williams 253,372 £8,589,311

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,390.00p
Change Today -50.00p
% Change -1.45 %
52 Week High 4,100.00
52 Week Low 2,950.00
Volume 1,046
Shares Issued 5.14m
Market Cap £174.34m
Beta 0.18

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.31% below the market average96.31% below the market average96.31% below the market average96.31% below the market average96.31% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Price Trend
26.80% above the market average26.80% above the market average26.80% above the market average26.80% above the market average26.80% above the market average
35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average
Income
41.72% below the market average41.72% below the market average41.72% below the market average41.72% below the market average41.72% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Growth
6.39% above the market average6.39% above the market average6.39% above the market average6.39% above the market average6.39% above the market average
31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average

Bioventix Dividends

  Latest Previous
  Final Special
Ex-Div 31-Oct-19 31-Oct-19
Paid 15-Nov-19 15-Nov-19
Amount 43.00p 47.00p

Trades for 05-Dec-2019

Time Volume / Share Price
14:16 190 @ 3,378.00p
11:33 156 @ 3,350.00p
11:31 180 @ 3,366.80p
11:31 200 @ 3,400.00p
09:38 25 @ 3,400.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page